milrinone and cilostamide

milrinone has been researched along with cilostamide in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (31.25)18.2507
2000's7 (43.75)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, CC; Edmondson, SD; Fisher, MH; Forrest, MJ; He, J; Hofsess, S; MacIntyre, E; Mastracchio, A; Metzger, J; O'Connor, N; Parmee, ER; Patel, K; Tong, X; Tota, MR; Van der Ploeg, LH; Varnerin, JP; Weber, AE; Wyvratt, MJ1
Hughes, RA; Manallack, DT; Thompson, PE1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Chen, G; Ke, H; Kunz, S; Martinelli, S; Robinson, H; Seebeck, T; Wan, Y; Wang, H1
Bode, DC; Brunton, LL; Kanter, JR1
Imai, A; Nashida, T; Shimomura, H1
Chun, SY; Conti, M; Hsueh, AJ; Tsafriri, A; Zhang, R1
Conti, M; Hanssen, RG; Hirsch, B; Hsueh, AJ; Kloosterboer, HJ; Tsafriri, A; Van de Kant, M; Wiersma, A1
de Koster, BM; Elferink, JG; VanUffelen, BE1
Armstrong, DT; Gilchrist, RB; Thomas, RE1
Conti, M; DePaolo, LV; Jensen, JT; Schwinof, KM; Stouffer, RL; Zelinski-Wooten, MB1
Dorigo, P; Floreani, M; Fossa, P; Menozzi, G; Mosti, L1
Adderley, S; Bowles, EA; Hanson, MS; Sprague, RS; Sridharan, M; Stephenson, AH1
Hashimoto, K; Ishima, T1
Andersen, GØ; Ata, SH; Dahl, CP; Levy, FO; Orstavik, O; Osnes, JB; Qvigstad, E; Riise, J; Skomedal, T1
Alam, MH; Lee, J; Miyano, T1

Reviews

1 review(s) available for milrinone and cilostamide

ArticleYear
The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.
    Journal of medicinal chemistry, 2005, May-19, Volume: 48, Issue:10

    Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP; Cyclic GMP; Drug Design; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Quantitative Structure-Activity Relationship; Xanthines

2005

Other Studies

15 other study(ies) available for milrinone and cilostamide

ArticleYear
Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors.
    Bioorganic & medicinal chemistry letters, 2003, Nov-17, Volume: 13, Issue:22

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cyclic Nucleotide Phosphodiesterases, Type 3; Drug Design; Kinetics; Phosphodiesterase Inhibitors; Pyridazines; Structure-Activity Relationship; Vinyl Compounds

2003
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Biological and structural characterization of Trypanosoma cruzi phosphodiesterase C and Implications for design of parasite selective inhibitors.
    The Journal of biological chemistry, 2012, Apr-06, Volume: 287, Issue:15

    Topics: Amino Acid Sequence; Bridged Bicyclo Compounds, Heterocyclic; Catalytic Domain; Conserved Sequence; Crystallography, X-Ray; Drug Design; Kinetics; Molecular Sequence Data; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Binding; Protein Structure, Secondary; Protozoan Proteins; Recombinant Proteins; Saccharomyces cerevisiae; Sulfonamides; Surface Properties; Trypanosoma cruzi

2012
Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
    Circulation research, 1991, Volume: 68, Issue:4

    Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Cyclic GMP; Heart Ventricles; Isoenzymes; Kinetics; Male; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Pyrrolidinones; Quinolones; Rats; Rats, Inbred Strains; Rolipram; Substrate Specificity

1991
Characterization of cyclic AMP phosphodiesterase isozymes in rat parotid gland.
    Archives of oral biology, 1995, Volume: 40, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Calcium; Calmodulin; Chromatography, Agarose; Cyclic GMP; Enzyme Activation; Isoenzymes; Kinetics; Male; Milrinone; Molecular Weight; Parotid Gland; Phosphodiesterase Inhibitors; Pyridones; Pyrrolidinones; Quinolones; Rats; Rats, Wistar; Rolipram

1995
Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors.
    Developmental biology, 1996, Sep-15, Volume: 178, Issue:2

    Topics: Animals; Cell Compartmentation; Cell Differentiation; Cells, Cultured; Cyclic AMP; Female; Gene Expression Regulation, Developmental; Meiosis; Milrinone; Oocytes; Phosphodiesterase Inhibitors; Pyridones; Pyrrolidinones; Quinolones; Rats; Rolipram

1996
Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents.
    The Journal of clinical investigation, 1998, Aug-01, Volume: 102, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Contraceptive Agents, Female; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Estrus; Female; Fertilization; Heart Rate; Hypoxanthine; Isoenzymes; Meiosis; Menotropins; Mice; Mice, Inbred C57BL; Milrinone; Oogenesis; Ovarian Follicle; Ovulation; Ovulation Induction; Phosphodiesterase Inhibitors; Pregnancy; Purinones; Pyridazines; Pyridones; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Rolipram; Second Messenger Systems; Substrate Specificity; Thiophenes

1998
Interaction of cyclic GMP and cyclic AMP during neutrophil migration: involvement of phosphodiesterase type III.
    Biochemical pharmacology, 1998, Oct-15, Volume: 56, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cell Movement; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Milrinone; Neutrophils; Phosphodiesterase Inhibitors; Pyridones; Quinolones; Thionucleotides

1998
Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation.
    Developmental biology, 2002, Apr-15, Volume: 244, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cattle; Cell Culture Techniques; Cells, Cultured; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Female; Granulosa Cells; Isoenzymes; Meiosis; Milrinone; Oocytes; Phosphodiesterase Inhibitors; Quinolones; Sensitivity and Specificity

2002
Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro.
    Human reproduction (Oxford, England), 2002, Volume: 17, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Feasibility Studies; Female; Macaca mulatta; Meiosis; Milrinone; Oocytes; Phosphodiesterase Inhibitors; Quinolones; Rolipram; Thiophenes

2002
Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone.
    Bioorganic & medicinal chemistry, 2003, Nov-03, Volume: 11, Issue:22

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Binding Sites; Cardiotonic Agents; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Humans; Milrinone; Models, Molecular; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinolones

2003
Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:2

    Topics: Adult; Aged; Animals; Blotting, Western; Cilostazol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 3; Drug Interactions; Erythrocyte Membrane; Female; Humans; Iloprost; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Quinolones; Rabbits; Tetrazoles; Up-Regulation

2008
Neurite outgrowth mediated by translation elongation factor eEF1A1: a target for antiplatelet agent cilostazol.
    PloS one, 2011, Mar-01, Volume: 6, Issue:3

    Topics: Animals; Cilostazol; Drug Synergism; Inositol 1,4,5-Trisphosphate Receptors; JNK Mitogen-Activated Protein Kinases; Milrinone; Mitogen-Activated Protein Kinase Kinases; Nerve Growth Factor; Neurites; PC12 Cells; Peptide Elongation Factor 1; Phosphatidylinositol 3-Kinases; Phosphodiesterase 3 Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Phospholipase C gamma; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolones; raf Kinases; ras Proteins; Rats; Receptor, trkA; Signal Transduction; Tetrazoles

2011
Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.
    British journal of pharmacology, 2014, Volume: 171, Issue:23

    Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiotonic Agents; Heart; Heart Failure; Humans; Hydrazones; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Contraction; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Pyridazines; Quinolines; Quinolones; Rats, Wistar; Rolipram; Simendan; Thiadiazines

2014
Inhibition of PDE3A sustains meiotic arrest and gap junction of bovine growing oocytes in in vitro growth culture.
    Theriogenology, 2018, Sep-15, Volume: 118

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cattle; Cell Communication; Cell Cycle Checkpoints; Cumulus Cells; Cyclic Nucleotide Phosphodiesterases, Type 3; Female; Gap Junctions; In Vitro Oocyte Maturation Techniques; Meiosis; Milrinone; Oocytes; Phosphodiesterase 3 Inhibitors; Quinolones

2018